Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Florida for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Florida only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Florida (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Tanuj Banker (NPI 1447542410)

Field	Value
Entity Type	Individual
Organization	Tanuj Banker
Address	2601 S Tamiami Trl
City	Sarasota
State	FL
ZIP	34239
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 10, 2011

Payer Source	Total Paid
Medicare	$7.7M
Medicaid	$0

Key Findings

This provider’s billing is effectively single‑payer: lifetime Medicare revenue is $7.7M and there is no Medicaid billing on file, so Medicare accounts for essentially all reported public program activity. Analysts should treat Medicare as the dominant payer when profiling utilization and financial exposure for this NPI.

Revenue is highly concentrated in a small number of drug injection codes: the precomputed top‑3 Medicare codes account for 72.5% of this provider’s total Medicare revenue, driven by J0178 ($3.4M, 44.1%), J2778 ($1.3M, 16.7%), and J2777 ($903.1K, 11.7%). This concentration implies that a large share of the provider’s Medicare receipts derive from intravitreal biologic treatments rather than broad primary‑care E/M or minor procedures.

The CPT/HCPCS mix is consistent with a high‑volume retina practice focused on intravitreal anti‑VEGF and related biologic therapies: top codes include J0178 (aflibercept), J2778 (ranibizumab), J2777 (faricimab), and the procedure code 67028 (vitreous chamber injection). Concurrently high usage of diagnostic imaging codes (92250, 92242, 92134) indicates in‑office imaging and interpretation capacity to support frequent injection follow‑ups and retinal disease management.

Several individual codes show national outlier status for volume, signaling market dominance in those services: J0178 ranks #28 of 3204 providers nationally (99th percentile; extreme outlier) and J2778 ranks #18 of 1208 providers nationally (99th percentile; notably above typical national volume). By contrast, J2777 is more typical at rank #279 of 2039 (86th percentile; typical, unremarkable volume), so the provider’s leadership is strongest for aflibercept and ranibizumab specifically.

High diagnostic and imaging throughput reinforces the operational model: 92242 ($216.7K) ranks #2 of 206 providers nationally (100th percentile; extreme outlier) and 92250 ($114.4K) ranks #2 of 25087 providers nationally (100th percentile; extreme outlier), with other imaging and electrophysiology codes (92235, 92273, 92134) also at elevated percentiles. These patterns point to a clinic workflow that pairs frequent injections with intensive retinal imaging and interpretation rather than episodic, low‑intensity ophthalmology visits.

Office visit E/M volumes are also elevated and align with procedure throughput: 99214 (2.6K claims, $234.5K, 3.0%) ranks #456 of 479517 providers nationally (100th percentile; extreme outlier) and 99213 (1.6K claims, $109.2K, 1.4%) ranks #1759 of 457151 providers nationally (100th percentile; extreme outlier). High E/M counts alongside injection and imaging volumes are consistent with repeat follow‑up and treatment visits typical of retina practices managing chronic conditions like wet AMD.

A notable portion of revenue is billed under J3490 (Unclassified drugs): 305 claims producing $426.1K (5.5% of Medicare revenue) and ranking #207 of 2838 providers nationally (93th percentile; typical, unremarkable volume). This material J3490 revenue suggests use of drugs or formulations billed outside established HCPCS codes and may warrant documentation review by payers to clarify the specific agents and billing rationale.

The provider has an established enrollment history (NPI enumerated 2011-05-10, ~15 years ago), and the sustained, concentrated high volumes across injection and imaging codes suggest a mature, procedure‑oriented retina specialty practice in Sarasota, FL. For network and utilization management, this profile points to stable, high‑intensity retinal care rather than a general ophthalmology practice.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	4,900	$690	$3.4M
J2778	Injection, ranibizumab, 0.1 mg	6,930	$190	$1.3M
J2777	Injection, faricimab‑svoa, 0.1 mg	31,140	$30	$903.1K
J3490	Unclassified drugs	310	$1,400	$426.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	3,980	$100	$394.3K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	1,690	$210	$361.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,610	$90	$234.4K
92242	The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He…	1,120	$190	$216.7K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	4,240	$30	$114.4K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,610	$70	$109.2K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Florida Distribution

Tanuj Banker — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Florida

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	4	250	800	$690	$817.6K
J2777	31	170	12,810	$30	$549.2K
J2778	4	110	660	$180	$234.1K
Q5128	9	40	770	$220	$216.3K
67028	6	300	710	$90	$91.1K
J3490	33	180	70	$280	$87.5K
92242	2	20	100	$200	$54.6K
J7312	34	40	230	$160	$45.5K
92014	1,966	2,180	160	$80	$28.5K
99214	107	32,760	140	$90	$25K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Tanuj Banker, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Michael Parrott	FL	Retina Specialist (Ophthalmology) Physician	$4.4M	$0
Veronica Kon Graversen	MS	Retina Specialist (Ophthalmology) Physician	$3.1M	$0
Jesse Mccann	FL	Retina Specialist (Ophthalmology) Physician	$2M	$0
Anita Shane	FL	Ophthalmology Physician	$1.6M	$0
Joshua Kim	FL	Ophthalmology Physician	$788K	$0
William Soscia	FL	Ophthalmology Physician	$667K	$0
David Shoemaker	FL	Ophthalmology Physician	$662.8K	$0
Joshua Newman	FL	Dermatology Physician	$626K	$0
Joaquin De Rojas	FL	Ophthalmology Physician	$574.3K	$0
Priya Mathews	FL	Cornea and External Diseases Specialist Physician	$483.9K	$0

Nearby Providers

Other providers in the same ZIP code as Tanuj Banker, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sarasota County Public Hospital District	FL	General Acute Care Hospital	$0	$16.5M
Rai Care Centers Of Sarasota LLC	FL	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$8.4M
Laser & Surgical Services At Center For Sight LLC	FL	Ambulatory Surgical Clinic/Center	$5.8M	$0
Christopher Stelton	FL	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Alexander Glick	FL	Medical Oncology Physician	$4M	$0
Daniel Kiernan	FL	Ophthalmology Physician	$2.7M	$572.1K
Luis Chu	FL	Medical Oncology Physician	$3.2M	$0
Kaitlin Lima	FL	Internal Medicine Physician	$2.7M	$0
Anjan Patel	FL	Medical Oncology Physician	$2.1M	$0
Noel Maun	FL	Medical Oncology Physician	$2M	$0

Tanuj Banker — Billing Profile & Reimbursement Data

Sign up for Tanuj Banker — Billing Profile & Reimbursement Data policy alerts

Tanuj Banker — Billing Profile & Reimbursement Data

Sign up for Tanuj Banker — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References